Manufacturers Life Insurance Company, The Vir Biotechnology, Inc. Transaction History

Manufacturers Life Insurance Company, The

$109 Billion
Q4 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 47,265 shares of VIR stock, worth $328,491. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,265

Previous 48,291 2.12%

Holding current value

$328,491

Previous $361,000 4.16%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$6.74 - $10.17 $6,915 - $10,434	-1,026 Reduced 2.12%	47,265 $346,000
Q3 2024 Nov 13, 2024	SELL	$7.26 - $10.7 $5,052 - $7,447	-696 Reduced 1.42%	48,291 $361,000
Q2 2024 Aug 14, 2024	BUY	$7.63 - $12.66 $27,506 - $45,639	3,605 Added 7.94%	48,987 $435,000
Q1 2024 May 14, 2024	BUY	$8.6 - $11.9 $10,354 - $14,327	1,204 Added 2.73%	45,382 $459,000
Q4 2023 Feb 13, 2024	SELL	$7.76 - $10.29 $7,465 - $9,898	-962 Reduced 2.13%	44,178 $444,000
Q3 2023 Nov 15, 2023	SELL	$9.14 - $24.62 $86,656 - $233,422	-9,481 Reduced 17.36%	45,140 $422,000
Q2 2023 Aug 11, 2023	BUY	$23.2 - $27.29 $557,426 - $655,696	24,027 Added 78.54%	54,621 $1.34 Million
Q1 2023 May 15, 2023	BUY	$22.26 - $30.85 $6,232 - $8,638	280 Added 0.92%	30,874 $718,000
Q4 2022 Aug 11, 2023	BUY	$19.96 - $28.22 $11,257 - $15,916	564 Added 1.88%	30,594 $774,000
Q4 2022 Feb 13, 2023	BUY	$19.96 - $28.22 $11,257 - $15,916	564 Added 1.88%	30,594 $774,000
Q3 2022 Aug 11, 2023	SELL	$18.26 - $31.1 $11,375 - $19,375	-623 Reduced 2.03%	30,030 $578,000
Q3 2022 Nov 03, 2022	SELL	$18.26 - $31.1 $11,375 - $19,375	-623 Reduced 2.03%	30,030 $579,000
Q2 2022 Aug 11, 2023	SELL	$19.08 - $26.7 $316,155 - $442,419	-16,570 Reduced 35.09%	30,653 $780,000
Q2 2022 Aug 15, 2022	SELL	$19.08 - $26.7 $316,155 - $442,419	-16,570 Reduced 35.09%	30,653 $781,000
Q1 2022 Aug 11, 2023	BUY	$21.19 - $40.01 $346,435 - $654,123	16,349 Added 52.95%	47,223 $1.21 Million
Q1 2022 May 20, 2022	BUY	$21.19 - $40.01 $334,272 - $631,157	15,775 Added 50.16%	47,223 $1.22 Million
Q4 2021 Feb 16, 2022	SELL	$30.97 - $54.03 $9,755 - $17,019	-315 Reduced 0.99%	31,448 $1.3 Million
Q3 2021 Nov 12, 2021	SELL	$34.9 - $54.54 $106,759 - $166,837	-3,059 Reduced 8.78%	31,763 $1.38 Million
Q2 2021 Aug 12, 2021	BUY	$38.75 - $51.0 $140,507 - $184,926	3,626 Added 11.62%	34,822 $1.65 Million
Q1 2021 May 03, 2021	SELL	$26.34 - $83.07 $51,125 - $161,238	-1,941 Reduced 5.86%	31,196 $1.6 Million
Q4 2020 Feb 12, 2021	BUY	$25.51 - $43.38 $36,989 - $62,901	1,450 Added 4.58%	33,137 $887,000
Q3 2020 Nov 09, 2020	BUY	$28.28 - $53.6 $81,446 - $154,368	2,880 Added 10.0%	31,687 $1.09 Million
Q2 2020 Aug 10, 2020	BUY	$27.89 - $47.86 $619,046 - $1.06 Million	22,196 Added 335.74%	28,807 $1.05 Million
Q1 2020 May 15, 2020	BUY	$12.04 - $60.2 $79,596 - $397,982	6,611 New	6,611 $227,000

Others Institutions Holding VIR

# of Institutions

231

Shares Held

90M

Call Options Held

1.28M

Put Options Held

235K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $922M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Vir Biotechnology, Inc. Transaction History